Sharon Winton, CEO of Lymphoma Australia and a passionate patient advocate, joins forces with industry leader Liz de Somer to dive into patient engagement. They discuss the urgent need for collaboration across healthcare, especially post-COVID-19. The conversation highlights how advancements in treatment options are empowering patients, while also addressing the complexities of engagement in the Australian pharmaceutical landscape. Winton emphasizes the importance of early patient involvement in clinical trials, ensuring patient values are at the forefront of care.
